US OptionsDetailed Quotes

IMUX250516P5000

Watchlist

3.85
-0.10-2.53%

15min DelayClose Apr 29 16:00 ET

3.85High3.85Low

Immunic Stock Discussion

Maddtrinity

4 hours ago

$Immunic (IMUX.US)$ tomorrow could be interesting

MANIPULATOR

7 hours ago

NO ONE SELLING. News by end of April…

$Immunic (IMUX.US)$ it looks like no one selling until this news comes out. Well, I’m not selling either! Good news doesn’t always drive a stock up, but this one has a lot of other catalyst on top of it. If the news comes out and it’s good like it’s supposed to be it’s gonna pop like a cork

MANIPULATOR

9 hours ago

Seeking Alpha article on IMUX 04/24/25 V Positive

$Immunic (IMUX.US)$ Excerpts INC NEWS DUE “This Month”! on Phase 2 Important MS drug!!

$Immunic (IMUX.US)$ 😎👀

Maddtrinity

Apr 24 03:11

$Immunic (IMUX.US)$ 👀

Trytosaveabit

Apr 19 18:11

Check it! Eyes on. NFA

$Immunic (IMUX.US)$ So been on a tiny, low volume uptrend since a Big Ole Bottom ( Likes me some BOB’s 🤭Hehehe ) on 4/9/25! Also was going through my notes earlier this morning and came across this lil reminder GEM in said notes ((((. A key upcoming milestone for Immunic is the phase two CALLIPER trial readout, expected in April. The trial is focused on progressive MS, and if results confirm the drug’s neuroprotective effects, it could be the first disease-modifying trea...

Jaguar8

Feb 26 20:28

NEWS

$Immunic (IMUX.US)$
Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis
Wednesday, 26th February at 6:30 am
– Vidofludimus Calcium's Activation of Nurr1 Reduces Neuronal Loss and Injury Directly and Indirectly By Decreasing Microglial Activations in Preclinical Models –
– Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April –
NEW YORK, Feb. 26, 2025 /PRNewswi...

Teddy123

Feb 26 19:38

Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis

$Immunic (IMUX.US)$
Can Immunic's MS Drug Protect Neurons? New Data Reveals Promising Mechanism Ahead of Critical Trial Results

Teddy123

Feb 20 20:49

Immunic's Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing

$Immunic (IMUX.US)$
Oral GLP-1 Breakthrough? New Drug Shows 250% Increase in Weight Loss Hormone

No comment yet